Imperial Innovation Fund, alongside Johnson & Johnson Foundation and Newtown Partners, invested USD 1.5M in Ghana-based health-tech startup Redbird to support its mission of improving healthcare accessibility through rapid diagnostic testing.

Target Information

Redbird, a Ghana-based health technology startup, empowers patients to efficiently manage their health through quick medical tests available at local community pharmacies. With a mission to revolutionize healthcare accessibility, Redbird allows users to access their digital health records via a dedicated application, ensuring that they can monitor their health effortlessly.

Founded in 2018 by Patrick Beattie and his team, Redbird offers ten different rapid tests performed at over 350 partner pharmacies across Ghana. These tests provide instant results that are stored in a personal health record accessible through the Redbird app, enhancing patient-centric healthcare delivery. Moreover, the platform encourages information sharing with healthcare professionals, given patient consent, to provide a comprehensive view of individual health histories.

Industry Overview

The healthcare landscape in Ghana is undergoing significant transformation, particularly in the health-tech sector. Rapid advancements in technology and increasing smartphone penetration are paving the way for innovative solutions aime

View Source

Similar Deals

JICA CarePoint

2025

Seed Stage Hospitals, Clinics & Primary Care Services Ghana
Vorwerk Ventures Carelane

2025

Seed Stage Biotechnology & Medical Research (NEC) Germany
启明创投 蔚程医药有限公司

2025

Seed Stage Advanced Medical Equipment & Technology (NEC) China
SC Launch Inc. NeuroQuest

2025

Seed Stage In-Vivo Diagnostic & Testing Substances United States of America
20VC, Kima Ventures La Fraise

2025

Seed Stage Healthcare Facilities & Services (NEC) France

Imperial Innovation Venture Fund

invested in

Redbird

in 2021

in a Seed Stage deal

Disclosed details

Transaction Size: $2M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert